Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva ...

Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, ...

Oppenheimer analyst Suraj Kalia lowered the firm’s price target on Varex Imaging (VREX) to $23 from $30 and keeps an Outperform rating on the ...

On Friday, Oppenheimer analysts upgraded EnerSys (NYSE ... Fluid & Combustion Systems (FC&S), and impacts from the 45X project, the core growth of EnerSys remains profitable and is likely to ...

According to a new rumor, Cillian Murphy (Peaky Blinders, Oppenheimer) is being eyed to play the duplicitous Quirinus ...

T-Mobile USA plans to raise 2.75 billion euros through a secondary public offering, with the proceeds used for corporate ...

Oppenheimer's analysis highlights Citigroup's journey since the Global Financial Crisis (GFC), noting that from 2012 to 2023, Citigroup's core Return on Tangible Common Equity (ROTCE) averaged 9.2 ...

Zurn Elkay Water Solutions Corporation (NYSE:ZWS) Q4 2024Management ViewCEO Todd Adams highlighted 4% core growth in Q4 ...

Jesse Garcia and Will Yun Lee sign on Christopher Nolan’s The Odyssey with its star-studded cast to deliver an epic IMAX ...

Heather Perry made a bold bet before last year's holiday rush: switch all e-commerce operations of her family-owned roastery, ...

Though we don't have much to go on, Academy Award-winner Cillian Murphy is rumored to be up for a key villainous role in HBO's upcoming Harry Potter series - and it's not Voldemort!